Global Trends in the Epidemiology and Management of Dyslipidemia

Dyslipidemia, especially a circulating non-optimal level of cholesterol, is one of the most important risk factors for atherosclerotic cardiovascular disease (ASCVD), which accounts for the most deaths worldwide. Maintaining a healthy level of blood cholesterol is an important prevention strategy fo...

Descripción completa

Detalles Bibliográficos
Autores principales: Liu, Tianxiao, Zhao, Dong, Qi, Yue
Formato: Online Artículo Texto
Lenguaje:English
Publicado: MDPI 2022
Materias:
Review
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9656679/
https://www.ncbi.nlm.nih.gov/pubmed/36362605
http://dx.doi.org/10.3390/jcm11216377
_version_ 1784829496621268992
author Liu, Tianxiao
Zhao, Dong
Qi, Yue
author_facet Liu, Tianxiao
Zhao, Dong
Qi, Yue
author_sort Liu, Tianxiao
collection PubMed
description Dyslipidemia, especially a circulating non-optimal level of cholesterol, is one of the most important risk factors for atherosclerotic cardiovascular disease (ASCVD), which accounts for the most deaths worldwide. Maintaining a healthy level of blood cholesterol is an important prevention strategy for ASCVD, through lifestyle intervention or cholesterol-lowering therapy. Over the past three decades, the epidemiology and management of dyslipidemia has changed greatly in many countries. Therefore, it is necessary to understand the current epidemiologic features of dyslipidemia and challenges from a global perspective.
format Online
Article
Text
id pubmed-9656679
institution National Center for Biotechnology Information
language English
publishDate 2022
publisher MDPI
record_format MEDLINE/PubMed
spelling pubmed-96566792022-11-15 Global Trends in the Epidemiology and Management of Dyslipidemia Liu, Tianxiao Zhao, Dong Qi, Yue J Clin Med Review Dyslipidemia, especially a circulating non-optimal level of cholesterol, is one of the most important risk factors for atherosclerotic cardiovascular disease (ASCVD), which accounts for the most deaths worldwide. Maintaining a healthy level of blood cholesterol is an important prevention strategy for ASCVD, through lifestyle intervention or cholesterol-lowering therapy. Over the past three decades, the epidemiology and management of dyslipidemia has changed greatly in many countries. Therefore, it is necessary to understand the current epidemiologic features of dyslipidemia and challenges from a global perspective. MDPI 2022-10-28 /pmc/articles/PMC9656679/ /pubmed/36362605 http://dx.doi.org/10.3390/jcm11216377 Text en © 2022 by the authors. https://creativecommons.org/licenses/by/4.0/Licensee MDPI, Basel, Switzerland. This article is an open access article distributed under the terms and conditions of the Creative Commons Attribution (CC BY) license (https://creativecommons.org/licenses/by/4.0/).
spellingShingle Review
Liu, Tianxiao
Zhao, Dong
Qi, Yue
Global Trends in the Epidemiology and Management of Dyslipidemia
title Global Trends in the Epidemiology and Management of Dyslipidemia
title_full Global Trends in the Epidemiology and Management of Dyslipidemia
title_fullStr Global Trends in the Epidemiology and Management of Dyslipidemia
title_full_unstemmed Global Trends in the Epidemiology and Management of Dyslipidemia
title_short Global Trends in the Epidemiology and Management of Dyslipidemia
title_sort global trends in the epidemiology and management of dyslipidemia
topic Review
url https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9656679/
https://www.ncbi.nlm.nih.gov/pubmed/36362605
http://dx.doi.org/10.3390/jcm11216377
work_keys_str_mv AT liutianxiao globaltrendsintheepidemiologyandmanagementofdyslipidemia
AT zhaodong globaltrendsintheepidemiologyandmanagementofdyslipidemia
AT qiyue globaltrendsintheepidemiologyandmanagementofdyslipidemia

Ejemplares similares